Heartburn drug suspended from sale

Heartburn drug suspended from sale - US retailer CVS has become the latest to suspend the sale of a heartburn drug being investigated for links to cancer. The move comes after concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European Union are investigating. Health authorities say there is no immediate risk, but patients have been advised to consult a doctor who can prescribe alternatives to ranitidine.

Last local news

Evening Update Friday 28 November 2025

President Macron has announced a ban on mobile phones in French high schools. Evening Update Friday 28 November 2025 Read More

28/11/2025

French and Riviera News Friday 28th November 2025

French gendarmes have issued a new appeal for information as the investigation into the killing of Karen Carter enters its seventh month with no major... French and Riviera News Friday 28th November 2025 Read More

28/11/2025

Evening Update Thursday 27 November 2025

President Macron has confirmed that voluntary national service will be introduced in France Evening Update Thursday 27 November 2025 Read More

27/11/2025

French and Riviera News Thursday 27th November 2025

The French government has suspended a planned rise in property tax until next spring, Prime Minister Sébastien Lecornu told the Senate on Wednesday. T... French and Riviera News Thursday 27th November 2025 Read More

27/11/2025

French and Riviera News Wednesday 26 November 2025

A homeless man accused of firing a shot which seriously injured another homeless person in Nice has appeared in court. The man in his fifties claimed ... French and Riviera News Wednesday 26 November 2025 Read More

25/11/2025